LIPOCINE INC. — Net Income by Fiscal Year
15 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/052e281f-32c8-41aa-a3af-e96a6eed077e/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-9.6M | 2025-01-01 – 2025-12-31 | evidence 0001493152-26-018335 |
| FY 2024 | $10.0k | 2024-01-01 – 2024-12-31 | evidence 0001493152-26-018335 |
| FY 2023 | $-16.4M | 2023-01-01 – 2023-12-31 | evidence 0001493152-26-018335 |
| FY 2022 | $-10.8M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-007178 |
| FY 2021 | $-634.4k | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-006353 |
| FY 2020 | $-21.0M | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-034761 |
| FY 2019 | $-13.0M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-032764 |
| FY 2018 | $-11.7M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-012434 |
| FY 2017 | $-21.0M | 2017-01-01 – 2017-12-31 | evidence 0001144204-18-013981 |
| FY 2016 | $-19.0M | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-012930 |
| FY 2015 | $-18.2M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-087232 |
| FY 2014 | $-20.4M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-015256 |
| FY 2013 | $-10.6M | 2013-01-01 – 2013-12-31 | evidence 0001144204-14-019291 |
| FY 2012 | $-85.0k | 2011-10-13 – 2013-03-31 | evidence 0001477932-13-001980 |
| FY 2011 | $-5.2k | 2011-01-01 – 2011-12-31 | evidence 0001477932-13-000891 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).